The Beta-2 Glycoprotein 1, IgM Test measures IgM antibodies against beta-2 glycoprotein, a protein involved in blood clotting. This test is primarily used to evaluate the risk of autoimmune disorders, particularly antiphospholipid syndrome (APS), a condition that increases the likelihood of blood clots. Elevated levels of these antibodies are often associated with autoimmune conditions that can lead to complications such as thrombosis, recurrent miscarriages, or other clotting issues. The test is prescribed to individuals with symptoms or a history suggestive of clotting disorders, as well as to monitor those with diagnosed autoimmune diseases.

The Beta-2 Glycoprotein 1, IgM Test is vital for assessing the risk of thrombotic (clotting) events, which are commonly linked to autoimmune disorders like antiphospholipid syndrome (APS). High levels of beta-2 glycoprotein IgM antibodies can indicate a greater risk of blood clots forming in veins or arteries, potentially leading to complications such as deep vein thrombosis, pulmonary embolism, or stroke. This test is crucial for individuals with symptoms or a family history of clotting disorders, recurrent miscarriages, or autoimmune diseases, allowing for timely diagnosis and management of potential risks.

Test price for other cities